dc.contributor.author
López Soley, Elisabet
dc.contributor.author
Meca Lallana, José E.
dc.contributor.author
Llufriu Duran, Sara
dc.contributor.author
Blanco, Yolanda
dc.contributor.author
Gómez Ballesteros, Rocío
dc.contributor.author
Maurino, Jorge
dc.contributor.author
Pérez Miralles, Francisco
dc.contributor.author
Forero, Lucia
dc.contributor.author
Calles, Carmen
dc.contributor.author
Martínez Ginés, María L.
dc.contributor.author
González Suárez, Inés
dc.contributor.author
Boyero, Sabas
dc.contributor.author
Romero Pinel, Lucía
dc.contributor.author
Sempere, Ángel P.
dc.contributor.author
Meca Lallana, Virginia
dc.contributor.author
Querol, Luís
dc.contributor.author
Costa Frossard, Lucienne
dc.contributor.author
Sepúlveda, María
dc.contributor.author
Solana, Elisabeth
dc.date.accessioned
2024-11-27T21:13:29Z
dc.date.available
2024-11-27T21:13:29Z
dc.date.issued
2024-03-05T09:58:26Z
dc.date.issued
2024-03-05T09:58:26Z
dc.date.issued
2023-07-19T09:38:42Z
dc.identifier
http://hdl.handle.net/2445/208384
dc.identifier.uri
http://hdl.handle.net/2445/208384
dc.description.abstract
The frequency of cognitive impairment (CI) reported in neuromyelitis optica spectrum disorder (NMOSD) is highly variable, and its relationship with demographic and clinical characteristics is poorly understood. We aimed to describe the cognitive profile of NMOSD patients, and to analyse the cognitive differences according to their serostatus; furthermore, we aimed to assess the relationship between cognition, demographic and clinical characteristics, and other aspects linked to health-related quality of life (HRQoL).This cross-sectional study included 41 patients (median age, 44 years; 85% women) from 13 Spanish centres. Demographic and clinical characteristics were collected along with a cognitive z-score (Rao's Battery) and HRQoL patient-centred measures, and their relationship was explored using linear regression. We used the Akaike information criterion to model which characteristics were associated with cognition.Fourteen patients (34%) had CI, and the most affected cognitive domain was visual memory. Cognition was similar in AQP4-IgG-positive and -negative patients. Gender, mood, fatigue, satisfaction with life, and perception of stigma were associated with cognitive performance (adjusted R2 = 0.396, p < 0.001).The results highlight the presence of CI and its impact on HRQoL in NMOSD patients. Cognitive and psychological assessments may be crucial to achieve a holistic approach in patient care.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.3390/jpm12050743
dc.relation
Journal of Personalized Medicine, 2022, vol. 12, num. 5
dc.relation
https://doi.org/10.3390/jpm12050743
dc.rights
cc by (c) Lopez Soley, Elisabet et al., 2022
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject
Malalties del sistema nerviós central
dc.subject
Central nervous system diseases
dc.title
Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion